Trigo Y - Search Results

1

Clinical classification of glaucomatous visual field loss by frequency doubling perimetry.

Sponsel WE, Arango S, Trigo Y, Mensah J. Sponsel WE, et al. Among authors: trigo y. Am J Ophthalmol. 1998 Jun;125(6):830-6. doi: 10.1016/s0002-9394(98)00047-6. Am J Ophthalmol. 1998. PMID: 9645720

2

Sildenafil increases ocular perfusion.

Paris G, Sponsel WE, Sandoval SS, Elliott WR, Trigo Y, Sanford DK, Harison JM. Paris G, et al. Among authors: trigo y. Int Ophthalmol. 2001;23(4-6):355-8. doi: 10.1023/a:1014410932321. Int Ophthalmol. 2001. PMID: 11944862

3

Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.

Harrison JM, Glickman RD, Ballentine CS, Trigo Y, Pena MA, Kurian P, Najvar LK, Kumar N, Patel AH, Sponsel WE, Graybill JR, Lloyd WC 3rd, Miller MM, Paris G, Trujillo F, Miller A, Melendez R. Harrison JM, et al. Among authors: trigo y. Doc Ophthalmol. 2005 Jan;110(1):37-55. doi: 10.1007/s10633-005-7342-0. Doc Ophthalmol. 2005. PMID: 16249956

4

Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma.

Sponsel WE, Paris G, Trigo Y, Pena M. Sponsel WE, et al. Among authors: trigo y. Am J Ophthalmol. 2002 Oct;134(4):552-9. doi: 10.1016/s0002-9394(02)01643-4. Am J Ophthalmol. 2002. PMID: 12383812 Clinical Trial.

5

Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.

Sponsel WE, Paris G, Trigo Y, Pena M, Weber A, Sanford K, McKinnon S. Sponsel WE, et al. Among authors: trigo y. Am J Ophthalmol. 2002 Jan;133(1):11-8. doi: 10.1016/s0002-9394(01)01286-7. Am J Ophthalmol. 2002. PMID: 11755835 Clinical Trial.

6

Comparison of the frequency doubling technology screening algorithm and the Humphrey 24-2 SITA-FAST in a large eye screening.

Allen CS, Sponsel WE, Trigo Y, Dirks MS, Flynn WJ. Allen CS, et al. Among authors: trigo y. Clin Exp Ophthalmol. 2002 Feb;30(1):8-14. doi: 10.1046/j.1442-9071.2002.00478.x. Clin Exp Ophthalmol. 2002. PMID: 11885802

7

Frequency of sustained glaucomatous-type visual field loss and associated optic nerve cupping in Beaver Dam, Wisconsin.

Sponsel WE, Shoemaker J, Trigo Y, Mensah J, Rugwani R, Garrett B. Sponsel WE, et al. Among authors: trigo y. Clin Exp Ophthalmol. 2001 Dec;29(6):352-8. doi: 10.1046/j.1442-9071.2001.d01-22.x. Clin Exp Ophthalmol. 2001. PMID: 11778803

8

Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye.

Sponsel WE, Mensah J, Kiel JW, Remky A, Trigo Y, Baca W, Friberg T. Sponsel WE, et al. Among authors: trigo y. Am J Ophthalmol. 2000 Aug;130(2):151-9. doi: 10.1016/s0002-9394(00)00401-3. Am J Ophthalmol. 2000. PMID: 11004288 Clinical Trial.

9

Frequency doubling perimetry.

Sponsel WE, Trigo Y, Hendricks J, Lloyd C. Sponsel WE, et al. Among authors: trigo y. Am J Ophthalmol. 1998 Jul;126(1):155-6. doi: 10.1016/s0002-9394(98)00235-9. Am J Ophthalmol. 1998. PMID: 9683173 No abstract available.

10

Dorzolamide hydrochloride and visual function in normal eyes.

Sponsel WE, Harrison J, Elliott WR, Trigo Y, Kavanagh J, Harris A. Sponsel WE, et al. Among authors: trigo y. Am J Ophthalmol. 1997 Jun;123(6):759-66. doi: 10.1016/s0002-9394(14)71124-9. Am J Ophthalmol. 1997. PMID: 9535619 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results